BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 20662852)

  • 1. MicroRNA profiling of multiple osteochondromas: identification of disease-specific and normal cartilage signatures.
    Zuntini M; Salvatore M; Pedrini E; Parra A; Sgariglia F; Magrelli A; Taruscio D; Sangiorgi L
    Clin Genet; 2010 Dec; 78(6):507-16. PubMed ID: 20662852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The neoplastic pathogenesis of solitary and multiple osteochondromas.
    Porter DE; Simpson AH
    J Pathol; 1999 Jun; 188(2):119-25. PubMed ID: 10398153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EXT genes are differentially expressed in bone and cartilage during mouse embryogenesis.
    Stickens D; Brown D; Evans GA
    Dev Dyn; 2000 Jul; 218(3):452-64. PubMed ID: 10878610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased EXT expression and intracellular accumulation of heparan sulphate proteoglycan in osteochondromas and peripheral chondrosarcomas.
    Hameetman L; David G; Yavas A; White SJ; Taminiau AH; Cleton-Jansen AM; Hogendoorn PC; Bovée JV
    J Pathol; 2007 Mar; 211(4):399-409. PubMed ID: 17226760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple osteochondromas: mutation update and description of the multiple osteochondromas mutation database (MOdb).
    Jennes I; Pedrini E; Zuntini M; Mordenti M; Balkassmi S; Asteggiano CG; Casey B; Bakker B; Sangiorgi L; Wuyts W
    Hum Mutat; 2009 Dec; 30(12):1620-7. PubMed ID: 19810120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secondary peripheral chondrosarcoma evolving from osteochondroma as a result of outgrowth of cells with functional EXT.
    de Andrea CE; Reijnders CM; Kroon HM; de Jong D; Hogendoorn PC; Szuhai K; Bovée JV
    Oncogene; 2012 Mar; 31(9):1095-104. PubMed ID: 21804604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tiling resolution array-CGH shows that somatic mosaic deletion of the EXT gene is causative in EXT gene mutation negative multiple osteochondromas patients.
    Szuhai K; Jennes I; de Jong D; Bovée JV; Wiweger M; Wuyts W; Hogendoorn PC
    Hum Mutat; 2011 Feb; 32(2):E2036-49. PubMed ID: 21280143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic models of osteochondroma onset and neoplastic progression: evidence for mechanisms alternative to EXT genes inactivation.
    Zuntini M; Pedrini E; Parra A; Sgariglia F; Gentile FV; Pandolfi M; Alberghini M; Sangiorgi L
    Oncogene; 2010 Jul; 29(26):3827-34. PubMed ID: 20418910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular basis of multiple exostoses: mutations in the EXT1 and EXT2 genes.
    Wuyts W; Van Hul W
    Hum Mutat; 2000; 15(3):220-7. PubMed ID: 10679937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytoskeletal abnormalities in chondrocytes with EXT1 and EXT2 mutations.
    Bernard MA; Hogue DA; Cole WG; Sanford T; Snuggs MB; Montufar-Solis D; Duke PJ; Carson DD; Scott A; Van Winkle WB; Hecht JT
    J Bone Miner Res; 2000 Mar; 15(3):442-50. PubMed ID: 10750558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple osteochondromas.
    Bovée JV
    Orphanet J Rare Dis; 2008 Feb; 3():3. PubMed ID: 18271966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defective chondrocyte proliferation and differentiation in osteochondromas of MHE patients.
    Benoist-Lasselin C; de Margerie E; Gibbs L; Cormier S; Silve C; Nicolas G; LeMerrer M; Mallet JF; Munnich A; Bonaventure J; Zylberberg L; Legeai-Mallet L
    Bone; 2006 Jul; 39(1):17-26. PubMed ID: 16476576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of EXT1 and EXT2, hereditary multiple exostoses gene products, in Golgi apparatus.
    Kobayashi S; Morimoto K; Shimizu T; Takahashi M; Kurosawa H; Shirasawa T
    Biochem Biophys Res Commun; 2000 Feb; 268(3):860-7. PubMed ID: 10679296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The short-lived exostosis induced surgically versus the lasting genetic hereditary multiple exostoses.
    Trebicz-Geffen M; Nevo Z; Evron Z; Posternak N; Glaser T; Fridkin M; Kollander Y; Robinson D
    Exp Mol Pathol; 2003 Feb; 74(1):40-8. PubMed ID: 12645631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An optimized DHPLC protocol for molecular testing of the EXT1 and EXT2 genes in hereditary multiple osteochondromas.
    Wuyts W; Radersma R; Storm K; Vits L
    Clin Genet; 2005 Dec; 68(6):542-7. PubMed ID: 16283885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EXT-related pathways are not involved in the pathogenesis of dysplasia epiphysealis hemimelica and metachondromatosis.
    Bovée JV; Hameetman L; Kroon HM; Aigner T; Hogendoorn PC
    J Pathol; 2006 Jul; 209(3):411-9. PubMed ID: 16622899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Signaling systems affecting the severity of multiple osteochondromas.
    Piombo V; Jochmann K; Hoffmann D; Wuelling M; Vortkamp A
    Bone; 2018 Jun; 111():71-81. PubMed ID: 29545125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Similar cytogenetic findings in two synchronous secondary peripheral chondrosarcomas in a patient with multiple osteochondromas.
    Kyriazoglou AI; Dimitriadis E; Arnogiannaki N; Brandal P; Heim S; Pandis N
    Cancer Genet; 2011 Dec; 204(12):677-81. PubMed ID: 22285020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysplasia epiphysealis hemimelica (Trevor disease): a rare developmental disorder of bone mimicking osteochondroma of long bones.
    Glick R; Khaldi L; Ptaszynski K; Steiner GC
    Hum Pathol; 2007 Aug; 38(8):1265-72. PubMed ID: 17490719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Germline mutations in the EXT1 and EXT2 genes in Korean patients with hereditary multiple exostoses.
    Park KJ; Shin KH; Ku JL; Cho TJ; Lee SH; Choi IH; Phillipe C; Monaco AP; Porter DE; Park JG
    J Hum Genet; 1999; 44(4):230-4. PubMed ID: 10429361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.